Valneva grabs flu vax approval in Japan; China to supply encephalitis jab to India in U-turn decision;

> Valneva has won approval for its EB66-based prototype influenza vaccine in Japan. Report

> China has flip-flopped on an earlier decision, agreeing to provide India with additional supplies of Japanese encephalitis vaccine for expansion of the Indian government's immunization program. Report

> GeoVax ($GOVX) has appointed Immunovaccine veteran Randal Chase to its board of directors. Release

> Measles vaccination must be scaled up in Ebola-affected countries, the World Health Organization says. More

> Immunovaccine has started a Phase II clinical trial of its DPX-Survivac cancer vaccine in recurrent lymphoma. Release

> Medigene has kicked off a Phase I/II study with DC Vaccine in patients with acute myeloid leukaemia. Release

And Finally... GIV Mobile is partnering up with the International Aids Vaccine Initiative (IAVI) to help fund R&D. More

Suggested Articles

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.

Former FDA Commissioner Scott Gottlieb says 40% of the population needs to be vaccinated to achieve COVID-19 herd immunity.

CanSino Bio, Moderna and a collaboration between Oxford Univeristy and AstraZeneca are frontrunners, but they all face hurdles shared and unique.